Radiobiological quantities in proton-therapy: Estimation and validation using Geant4-based Monte Carlo simulations.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 08 02 2018
revised: 30 01 2019
accepted: 30 01 2019
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 26 3 2019
Statut: ppublish

Résumé

The Geant4 Monte Carlo simulation toolkit was used to reproduce radiobiological parameters measured by irradiating three different cancerous cell lines with monochromatic and clinical proton beams. The experimental set-up adopted for irradiations was fully simulated with a dedicated open-source Geant4 application. Cells survival fractions was calculated coupling the Geant4 simulations with two analytical radiobiological models: one based on the LEM (Local Effect Model) approach and the other on a semi-empirical parameterisation. Results was evaluated and compared with experimental data. The results demonstrated the Geant4 ability to reproduce radiobiological quantities for different cell lines.

Identifiants

pubmed: 30824153
pii: S1120-1797(19)30018-3
doi: 10.1016/j.ejmp.2019.01.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-80

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Auteurs

G Petringa (G)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; Dipartimento di Fisica e Astronomia, Universitá degli Studi di Catania, Via S. Sofia 64, 95123 Catania, Italy.

F Romano (F)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; National Physical Laboratory, Acoustic and Ionizing Radiation Division, Teddington TW11 0LW, Middlesex, UK.

L Manti (L)

Dipartimento di Fisica E. Pancini, Universitá degli Studi Federico II di Napoli, Via Cinthia, I-80126 Napoli, Italy; INFN-NA, Istituto Nazionale di Fisica Nucleare, Sezione di Napoli, Complesso Universitario di M. S. Angelo, Via Cintia, I-80126 Napoli, Italy.

L Pandola (L)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy.

A Attili (A)

INFN-TO, Istituto Nazionale di Fisica Nucleare, Sezione di Torino, Torino, Italy.

F Cammarata (F)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; IBFM-CNR, Institute of Molecular Bioimaging and Physiology - National Research Council, Cefalù, PA, Italy.

G Cuttone (G)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy.

G Forte (G)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; IBFM-CNR, Institute of Molecular Bioimaging and Physiology - National Research Council, Cefalù, PA, Italy.

L Manganaro (L)

INFN-TO, Istituto Nazionale di Fisica Nucleare, Sezione di Torino, Torino, Italy.

J Pipek (J)

ELI-Beamline Project, Inst. Physics, ASCR, PALS Center, Prague, Czech Republic.

P Pisciotta (P)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; Dipartimento di Fisica e Astronomia, Universitá degli Studi di Catania, Via S. Sofia 64, 95123 Catania, Italy.

G Russo (G)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; IBFM-CNR, Institute of Molecular Bioimaging and Physiology - National Research Council, Cefalù, PA, Italy.

G A P Cirrone (GAP)

INFN-LNS. Istituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy; ELI-Beamline Project, Inst. Physics, ASCR, PALS Center, Prague, Czech Republic. Electronic address: pablo.cirrone@lns.infn.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH